Boston Scientific CorporationBSXNYSE
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+15.1%
5Y CAGR+12.7%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
+15.1%/yr
vs +6.2%/yr prior
5Y CAGR
+12.7%/yr
Consistent
Acceleration
+8.9pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.8x
Solid growth
Streak
5 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $6.89B | +15.1% |
| 2024 | $5.98B | +15.3% |
| 2023 | $5.19B | +14.8% |
| 2022 | $4.52B | +5.5% |
| 2021 | $4.29B | +13.2% |
| 2020 | $3.79B | -3.6% |
| 2019 | $3.93B | +10.4% |
| 2018 | $3.56B | +8.4% |
| 2017 | $3.28B | +6.4% |
| 2016 | $3.08B | - |